Evidence map›Paper›PMID 36148330›Full record

ArticleFrontiers in public health2022

COVID-19 vaccine uptake among people who inject drugs in Tijuana Mexico.

Alicia Harvey-Vera, Sheryl Munoz, Irina Artamonova, Daniela Abramovitz, Maria Luisa Mittal, Cecilia Rosales, Steffanie A Strathdee, Maria Gudelia Rangel

Abstract read
In one paragraph

Article in Frontiers in public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Alicia Harvey-VeraDivision of Infectious Diseases and Global Public Health, Department of Medicine, University of California, San Diego, San Diego, CA, United States.
Sheryl MunozUS-Mexico Border Health Commission, Tijuana, Mexico.
Irina ArtamonovaDivision of Infectious Diseases and Global Public Health, Department of Medicine, University of California, San Diego, San Diego, CA, United States.
Daniela AbramovitzDivision of Infectious Diseases and Global Public Health, Department of Medicine, University of California, San Diego, San Diego, CA, United States.
Maria Luisa MittalDivision of Infectious Diseases and Global Public Health, Department of Medicine, University of California, San Diego, San Diego, CA, United States.
Cecilia RosalesMel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ, United States.
Steffanie A StrathdeeDivision of Infectious Diseases and Global Public Health, Department of Medicine, University of California, San Diego, San Diego, CA, United States.
Maria Gudelia RangelUS-Mexico Border Health Commission, Tijuana, Mexico.

Funding

VirologyP30AI036214 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Maile Ann Young Karris · 1994 to 2026
$78.4M
UC San Diego Clinical and Translational Research InstituteKL2TR001444 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DEPP, COLIN A. · 2015 to 2024
$15.4M
Ethno-epidemiology of HCV, HIV and Overdose associated with Drug Marketsand Drug TourismR01DA049644 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI STRATHDEE, STEFFANIE A. · 2020 to 2024
$8.2M
NCATS NIH HHS KL2 TR001444NIAID NIH HHS P30 AI036214NIDA NIH HHS R01 DA049644
6 · The paper itself

Abstract

Background: SARS-CoV-2 prevalence is elevated among people who inject drugs (PWID). In Tijuana, Mexico, COVID-19 vaccines became available to the general population in June 2021, but uptake among PWID was <10%. We studied COVID-19 vaccine uptake among PWID in Tijuana following implementation of a pop-up vaccination clinic. Methods: Beginning in October, 2020, PWID in Tijuana aged ≥18 years were enrolled into a longitudinal cohort study. At baseline and semi-annually, participants underwent interviewer-administered interviews on health behaviors and COVID-19 exposures through April 5, 2022. From June 21-September 20, 2021, staff referred PWID to a temporary COVID-19 vaccine pop-up clinic that was coincidentally established near the study office. Participants attending the clinic completed a short interview on barriers to vaccination and were offered facilitated access to free Janssen® COVID-19 vaccine. All participants were reimbursed $5 for this interview, regardless of whether or not they chose to be vaccinated. Poisson regression was used to evaluate the effect of the pop-up clinic on COVID-19 vaccination uptake, controlling forpotential confounders. Results: Of 344 participants, 136 (39.5%) reported having received at least one COVID-19 vaccine dose during the 10 months follow-up period, of whom 113 (83.1%) received vaccine at the pop-up clinic and 23 (16.9%) elsewhere. One third of those receiving COVID-19 vaccine during the pop-up clinic were previously vaccine hesitant. Attending the pop-up clinic was independently associated with higher rates of COVID-19 vaccination Adjusted Rate Ratio (AdjRR: 9.15; 95% CI: 5.68-14.74). Conclusions: We observed a significant increase in COVID-19 vaccine uptake associated with attending a temporary pop-up vaccine clinic in Tijuana suggesting that efforts to improve vaccination in this vulnerable population should include convenient locations and staff who have experience working with substance using populations. Since COVID-19 vaccination rates remain sub-optimal, sustained interventions to increase uptake are needed.

Indexed as

COVID-19Drug UsersSubstance Abuse, IntravenousAdolescentAdultCOVID-19 VaccinesHumansLongitudinal StudiesMexicoSARS-CoV-2COVID-19 VaccinesCOVID-19COVID-19 vaccinespeople who inject drugssex worksubstance use

Identifiers

PMID36148330
PMCPMC9485825

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.